Diroximel fumarate
CAS: 1577222-14-0
Ref. 3D-CNC22214
| 10mg | Nachfragen | |
| 25mg | Nachfragen | |
| 50mg | Nachfragen | |
| 100mg | Nachfragen | |
| 250mg | Nachfragen |
Produktinformation
Dioximel is a drug that has been approved for the treatment of psoriasis. It has a profile of symptoms that are similar to those of psoriasis, and it also inhibits the growth factor called TNF-α. Dioximin is currently being evaluated in a clinical study for its efficacy in treating psoriatic arthritis. Dioximel is being studied as an anti-inflammatory agent to treat rheumatoid arthritis, osteoarthritis, and other inflammatory diseases. The mechanism of action of dioximel may be due to the inhibition of TNF-α production or by triggering apoptosis in cells where TNF-α is present. This drug has been shown to have no significant adverse effects on body mass index or lipid levels. There are no known interactions with other drugs that inhibit tumor necrosis factor activity.
Chemische Eigenschaften
Technische Anfrage zu: 3D-CNC22214 Diroximel fumarate
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
